Get started
Author

Donghoon Choi

Observed name: Dong-Hoon Choi
ORCID: 0009-0005-7237-8779
Observed ORCID: 0009-0005-7237-8779
OpenAlex ID: A5102948595
Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1
2011 · Mi-Young Song, Sang-Hoon Park, et al. · Journal of Immunotherapy · 131
hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects
2020 · Sang Won Lee, Donghoon Choi, et al. · Clinical and Translational Science · 50
PDF
Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells
2016 · Young Woo Choi, Moon Cheol Kang, et al. · Clinical Cancer Research · 38
PDF
Harnessing the Power of IL-7 to Boost T Cell Immunity in Experimental and Clinical Immunotherapies
2024 · Jung-Hyun Park, Seung-Woo Lee, et al. · Immune Network · 36
PDF
Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy
2020 · Ji‐Hae Kim, Young‐Min Kim, et al. · Clinical & Translational Immunology · 34
PDF
Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection
2015 · Moon Cheol Kang, Dong-Hoon Choi, et al. · Journal of Virology · 31
PDF
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
2023 · Julie O’Neal, Matthew L. Cooper, et al. · Blood Advances · 29
PDF
Biophysical stability of hyFc fusion protein with regards to buffers and various excipients
2016 · Jun Yeul Lim, Nam Ah Kim, et al. · International Journal of Biological Macromolecules · 26
Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
2013 · Hong Namkoong, Mi-Young Song, et al. · Vaccine · 24
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
2022 · Sojeong Kim, Sang Won Lee, et al. · Blood Advances · 19
PDF
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors
2024 · Minji Lee, Sun-Kyoung Im, et al. · Journal for ImmunoTherapy of Cancer · 14
PDF
GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours
2025 · Gun Min Kim, Sojeong Kim, et al. · British Journal of Cancer · 13
PDF
Fc-fused IL-7 provides broad antiviral effects against respiratory virus infections through IL-17A-producing pulmonary innate-like T cells
2024 · Dong-il Kwon, Subin Park, et al. · Cell Reports Medicine · 12
Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
2017 · Moon Cheol Kang, Han Wook Park, et al. · Immune Network · 9
PDF
Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy
2024 · Yeon-Woo Kang, Donghoon Choi, et al. · Frontiers in Immunology · 8
PDF
Fc-fused IL-7 mobilizes long-term HSCs in a pro-B cell-dependent manner and synergizes with G-CSF and AMD3100
2021 · Sora Kim, Young-Min Kim, et al. · Leukemia · 7
PDF
Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma
2026 · Yuping Derek Li, David A. Giles, et al. · Nature Communications · 5
Dose Optimization of rhIL ‐7‐ hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor‐Mediated Recycling‐Based and Target‐Mediated Drug Disposition Pharmacokinetic Model
2025 · Hye Seon Jeon, Sang Won Lee, et al. · Clinical and Translational Science · 5
PDF
Preclinical safety assessment of a therapeutic human papillomavirus DNA vaccine combined with intravaginal interleukin-7 fused with hybrid Fc in female rats
2021 · Kang-Hyun Han, Min Seong Jang, et al. · Toxicology and Applied Pharmacology · 4
NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model
2025 · Yee Peng Phoon, Alexandra A. Wolfarth, et al. · Scientific Reports · 3
PDF
Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines
2025 · Michael Chen, Thomas Kane, et al. · Cancers · 2
PDF
In vivo efficacy of BCMA-iNKT-CAR is enhanced by NT-I7, a long-acting IL-7
2019 · Julie O'Neal, Julie Ritchey, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Abstract 4991: Hyleukin-7, the Fc-fused interleukin-7, generates anti-tumor activity by modulating both adaptive and innate immune cells in the tumor microenvironment
2019 · Ji-Hae Kim, Sung-Wook Hong, et al. · Cancer Research · 2
Efineptakin alfa (NT-I7) improves overall survival and induces immune niches in murine tumors
2026 · Trang Dinh, Judong Lee, et al. · Genes & Diseases · 1
Long-acting IL-7 (NT-I7, efineptakin alfa) after CD19 CAR T-cell therapy for large B-cell lymphoma: a phase 1b trial
2026 · Zachary D. Crees, Michael P. Rettig, et al. · Blood Immunology & Cellular Therapy
PDF
Works count: 34
Citation count: 505
H-index: 12
I10-index: 13
Year
Topic
Type